Neuralink

Dandy

Neuralink

Neuralink doesn't have a traditional revenue model yet — it's still in clinical trials. The near-term plan is medical devices sold to hospitals and clinics for treating neurological conditions.

Brain-computer interfaces for paralysis, ALS, blindness, and other conditions would be reimbursed by insurance and healthcare systems, similar to cochlear implants or deep brain stimulators.

The long-term vision is consumer neurotechnology — healthy people choosing to get brain implants for enhanced cognition, communication, or AI interaction. This is years or decades away and faces massive regulatory and ethical hurdles.

But if it works, the total addressable market is literally every human brain on the planet.

The surgical robot is potentially a separate revenue stream. Even if the implant itself doesn't dominate, the precision robotics technology developed for neural surgery could be licensed to other medical device companies.

Neuralink has also built custom chip fabrication capabilities that could have applications beyond brain interfaces.

Dandy

Vertical SaaS plus manufacturing. Dandy provides dental practices with intraoral scanners (often subsidized or free to eliminate the switching cost), cloud-based software for managing cases, and its own network of digital dental labs that manufacture the final restorations.

Dentists pay per case — each crown, bridge, veneer, or implant restoration is priced individually. The margin comes from manufacturing efficiency: digital workflows are faster, more precise, and require less manual labor than traditional hand-sculpted methods.

As volume grows, Dandy's labs get more efficient and per-unit costs drop. It's the classic razor-and-blades model — give away the scanner, make money on every restoration.

Neuralink

Elon Musk had been talking about brain-computer interfaces publicly since at least 2016. His stated motivation was existential: if AI becomes superintelligent, humans need a way to merge with it or risk becoming irrelevant.

The solution, in his mind, was a direct neural link between the human brain and computers.

Neuralink was quietly incorporated in July 2016 in California. Musk recruited a team of eight co-founders — neuroscientists, engineers, and chip designers from institutions like UC Berkeley, MIT, and Lawrence Livermore National Laboratory.

The founding team included Ben Rapoport, a neurosurgeon who understood both the medical and engineering sides, and Dongjin Seo, who had done PhD research on neural dust (tiny wireless brain sensors).

The company operated in stealth for two years before a 2019 presentation where Musk revealed the vision: a coin-sized device implanted in the skull containing thousands of ultra-thin electrode threads inserted into the brain by a custom-built surgical robot. The threads are thinner than a human hair — roughly 5 microns wide — and each one contains multiple electrodes that read neural signals.

The robot was necessary because no human surgeon could place threads that thin without damaging brain tissue.

Dandy

Henry Stott was a repeat entrepreneur who had previously co-founded a tech company in the UK. When he looked at the dental industry, he saw a $15 billion lab market that was shockingly analog.

Here's how it worked: a dentist jams a tray of gooey putty into your mouth, waits for it to harden, mails the physical mold to a dental lab, where a technician hand-sculpts your crown out of ceramic. Turnaround: 2 to 3 weeks.

Error rate: high. Patient experience: miserable.

The technology to do this digitally had existed for years — 3D intraoral scanners, CAD/CAM software, CNC milling machines — but nobody had stitched it into a seamless end-to-end platform for the average dental practice. Stott started Dandy in 2020 to be that platform.

Provide the scanner, build the software, run the lab — and make it so easy that any dentist can switch from analog to digital without changing how they practice.

Neuralink

Neuralink's growth strategy is the classic Musk playbook: start with the premium use case that justifies the cost, then scale down. Phase 1 is medical — treat severe neurological conditions where no other option exists.

Quadriplegia, ALS, locked-in syndrome. Patients who literally cannot move or speak are willing to undergo experimental brain surgery.

The FDA granted Breakthrough Device designation in 2020, and the first human trial (PRIME study) began in 2024.

Phase 2 is expanding medical indications — blindness, depression, epilepsy, Parkinson's. Each new condition multiplies the patient population and the regulatory pathway, building clinical evidence along the way.

Phase 3 — the moonshot — is consumer enhancement. Musk has described this as "conceptual telepathy," where you think a message and it sends.

This phase requires proving extraordinary safety over years of medical use first. Nobody is going to electively implant a brain chip unless the medical version has been proven safe for a decade.

Dandy

Land-and-expand with dental practices. Dandy gives practices the scanner for free or at heavy discount, which eliminates the biggest barrier to switching from analog.

Once a practice starts submitting digital scans, they become recurring revenue — every patient who needs a crown is a Dandy order. Sales team targets mid-size practices (3 to 10 dentists) that are high-volume but haven't invested in digital yet.

Referral programs where existing dentists recommend Dandy to colleagues. Geographic density strategy — build lab capacity in a region, then saturate practices nearby to optimize logistics and turnaround times.

Content marketing educating dentists on why digital is better, faster, and more profitable than analog workflows.

Neuralink

The FDA and regulatory approval process is the primary bottleneck. Brain implants are Class III medical devices — the highest risk category.

Every design change, every new indication, requires extensive clinical data. The USDA also investigated Neuralink in 2022 for potential animal welfare violations in their primate testing program, which created PR headaches.

Long-term biocompatibility is an unsolved problem. The brain treats any foreign object as an invader and forms scar tissue around it, which can degrade signal quality over time.

Making an implant that works reliably for decades inside a hostile biological environment is one of the hardest engineering problems in medicine. Neuralink's thread retraction issue in their first human patient — where some threads pulled away from the brain — highlighted how much work remains.

Talent retention has been rocky. Max Hodak, the original president, left in 2021.

Several founding scientists departed. Working for Musk is notoriously demanding, and the timeline pressure on a medical device company clashes with the inherent need for cautious, methodical development.

Dandy

Dental practices are notoriously resistant to change — many dentists have used the same lab for 20 years and switching feels risky. The scanner hardware is expensive to subsidize at scale, creating a capital-intensive land grab.

Quality control across distributed manufacturing is hard — a crown that doesn't fit means a remake, an unhappy patient, and a dentist who might switch back to their old lab. Competition from established digital players like Align Technology and legacy lab companies investing in their own digital capabilities.

The dental industry is fragmented — 200,000+ practices in the US, mostly small businesses, which means enterprise-style sales don't work. Each practice is its own decision maker with its own habits.

Neuralink

The N1 Implant — a coin-sized device (23mm diameter, 8mm thick) implanted flush with the skull containing a custom chip that wirelessly transmits neural data to external devices via Bluetooth. The R1 Robot — a precision surgical system that inserts 1,024 electrode threads into the brain with micron-level accuracy, avoiding blood vessels using computer vision.

The N1 User App — software that translates neural signals into computer commands, allowing users to control cursors, keyboards, and eventually robotic limbs through thought alone. BCI Software Platform — the signal processing and machine learning stack that decodes raw brain signals into intended actions.

Dandy

Dandy Scanner — provided to dental practices, captures a full 3D digital impression of the patient's mouth in minutes. No more putty molds.

Cloud-based case management platform where dentists submit scans, approve designs, and track orders. AI-powered restoration design that generates crown and veneer designs automatically from 3D scans, reducing turnaround from weeks to days.

Digital dental lab network with automated CNC milling and 3D printing for manufacturing restorations. Shade matching technology using AI to color-match restorations to surrounding teeth.

Integration with practice management software so cases flow seamlessly from scan to delivery.

Neuralink

Elon Musk has been the primary funder, investing hundreds of millions of his personal wealth. The company raised $205 million in a Series C in 2021, then $280 million in a Series D in 2023 led by Founders Fund (Peter Thiel's firm).

A 2024 round reportedly valued the company at $8.9 billion. Google Ventures (GV) and DFJ Growth have also participated.

The investor base is narrow compared to most startups at this valuation.

Dandy

Investors include Bessemer Venture Partners, IVP, DST Global, and IA Ventures. Series C in 2023 valued the company at approximately $1.8 billion.